The central purpose of external quality assessment is to ensure that laboratories are delivering a service of the highest possible quality. EMQN maintains the principle of assessment by professional consensus and attempts to improve standards by education and peer group review rather than by censure or penalty. Performance criteria are necessary to allow an individual laboratory’s performance to be measured against national/international standards and to identify any laboratory which is failing to meet these criteria. Participants who fall below the standards detailed in the following documents are deemed to be performing poorly.
The performance criteria for poor performance and persistent poor performance are ratified by the EMQN Board and endorsed (where required) by the relevant national performance monitoring organisation (for example, the UK National Quality Assessment Advisory Panel (NQAAP) for Genetics for UK labs). Performance scores and relevant raw data may be shared with the relevant Advisory Panel (UK), FOPH (Switzerland), RCPAQAP (Australia) or relevant organisation (all countries) under defined circumstances.
Performance criteria for our Molecular Pathology Schemes can be found here.
Performance criteria for our Disease-specific and Technical schemes can be found here.
We measure rates of poor performance in all our EQA schemes (except Pilots). Poor performance is incurred for the following reasons and applies to all laboratories. Performance criteria can be found here.
- Non-submission of results with no acceptable prior notification to EMQN or self-withdrawal from the EQA scheme
- Critical Genotyping Error (false positive or false negative result)
- Critical Interpretation Error which adversely affects patient clinical management
- Incorrect/inappropriate advice.
All poor performance is ratified by the EMQN Board without disclosing the identity of the laboratory. Laboratories that have received a poor performance will be advised to perform a root cause analysis and may, if they wish, provide a summary of corrective and preventative actions to EMQN.
Persistent Poor Performance
Laboratories who perform poorly in two out of any three consecutive EQA rounds or incur a poor performance within one year following a previous persistent poor performance designation will be classed as “red” whilst the persistent poor performance status stands.
Laboratories performing poorly on genotyping in one round of EQA and interpretation in the next round will have the same consequences as performing poorly on genotyping for two rounds of EQA. A participant who has performed poorly for more than one disease/EQA in more than one EQA round may, at the discretion of the EMQN Director, be referred to the EMQN Board for Persistent Poor Performance even if they have not met the criteria for Persistent Poor Performance in any individual EQA.
Once a Swiss, Australian or UK laboratory meets the criteria for a persistent poor performance, the Scheme is obliged to notify FOPH (Swiss) or RCPAQAP (Australia), or NQAAP for Genetics (UK) respectively.[MC
[MCI would ask NW to review this section